1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Old URL (NOT-CA-25-020) was a Notice of Intent. Current NOFO is PAR-27-062; see NCI K32 page for standard receipt dates.
NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32) is a grant from the National Cancer Institute (NCI) that funds early postdoctoral fellows from diverse backgrounds, including underrepresented groups, to pursue research training in cancer-related fields. The K32 award supports fellows within 12 months prior to transitioning into, or within the first two years of, a postdoctoral position.
The program, operated through NCI's Center to Reduce Cancer Health Disparities (CRCHD), aims to enhance the pool of qualified diverse cancer researchers. Beginning with the June 12, 2025 due date, the CURE ACE Award is available in both Independent Clinical Trial Required and Independent Clinical Trial Not Allowed versions. Eligible applicants must be U.S. citizens or permanent residents at time of award.
Get alerted about grants like this
Get emailed when new opportunities from “National Cancer Institute (NCI)” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
NOT-CA-25-020: Notice of Intent to Publish Funding Opportunity Announcement for NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32 - Independent Clinical Trial Required) Notice of Intent to Publish Funding Opportunity Announcement for NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32 - Independent Clinical Trial Required) Estimated Publication Date of Notice of Funding Opportunity : First Estimated Application Due Date: Earliest Estimated Award Date: Earliest Estimated Start Date: National Cancer Institute ( NCI ) The Center to Reduce Cancer Health Disparities (CRCHD) at NCI is planning to issue two new Notice of Funding Opportunity announcements (NOFO), the NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32), which will be published in two versions: Independent Clinical Trial Required and Independent Clinical Trial Not Allowed.
Beginning with the June 12, 2025, due date, the CURE ACE Award will support research training for early postdoctoral fellows in cancer research. The funding program aims to enhance the pool of qualified individuals for careers that have a significant impact on the health-related research needs of the Nation and enrich the scientific cancer research experience of trainees as they transition from pre-doctoral to post-doctoral training.
This Notice is being provided to allow sufficient time for applicants to develop strong applications. The NCI CURE ACE funding program supports post-doctoral training for candidates from diverse backgrounds in cancer research. It allows them to apply during the late pre-doctoral or early postdoctoral stages, even without preliminary data .
Applicants must identify a postdoctoral research mentor and establish a comprehensive research and training plan before or soon after beginning with the postdoctoral mentor. The program is open to pre- and post-doctoral scientists conducting research across all areas of cancer research.
Applicants must identify their postdoctoral mentor and submit their application through the institution where they plan to conduct their postdoctoral research.
The NCI CURE Academic Career Excellence (ACE) funding program supports early post-doctoral fellows from diverse backgrounds, including individuals from underrepresented backgrounds ( NOT-OD-20-031 ) who bring life experiences, geographic location, socioeconomic status, academic training, professional experience, disability status, military service, career stage, institutional affiliation, cultural background, and other factors that may contribute to unique perspectives to the research workforce, and who are committed to a career in basic biomedical, clinical, behavioral or Translational cancer research, including research on cancer health disparities.
Research Initiative Details For the purpose this funding program eligible candidates must be within 12 months prior to transitioning into a postdoctoral position or within the first two years of their postdoctoral research at the time of submission and/or resubmission of their application. By the time of the award, the applicant must be a U.S. Citizen or permanent resident.
The NCI CURE Academic Career Excellence (ACE) funding program provides for up to three years of support, offering a competitive salary and research funding support to retain the talents and enhance their training and development in cancer research. Importantly, receiving this award will not affect an applicants eligibility for other independent career development programs such as CURE K01, CURE K08, and CURE K22 programs.
Indeed, we believe this funding program will equip awardees with the necessary skills and experience to prepare more competitive applications in the future. Therefore, it is expected that awardees begin working on their individual career development applications (e.g. K01/K08/K22) once they secured K32 funding to maximize their potential for future funding.
As this is a pilot program, the number of awards will be determined based on the volume and quality of applications received. The Center to Reduce Cancer Health Disparities (CRCHD) at NCI is committed to fostering diversity in the cancer research workforce through this innovative funding opportunity.
Expected Number of Awards Primary Assistance Listing Number(s) Anticipated Eligible Organizations Public/State Controlled Institution of Higher Education Private Institution of Higher Education Nonprofit with 501(c)(3) IRS Status (Other than Institution of Higher Education) For-Profit Organization (Other than Small Business) Indian/Native American Tribal Government (Federally Recognized) Independent school districts Public housing authorities/Indian housing authorities Indian/Native American Tribally Designated Organization (Native American tribal organizations (other than Federally recognized tribal governments) U.S. Territory or Possession Indian/Native American Tribal Government (Other than Federally Recognized) Eligible Agencies of the Federal Government Applications are not being solicited at this time.
National Cancer Institute (NCI) The Center to Reduce Cancer Health Disparities (CRCHD) Weekly TOC for this Announcement NIH... Turning Discovery Into Health ®
According to the current listing, eligibility includes: Within 12 months prior to transitioning into postdoctoral position or within first 2 years of postdoctoral research at submission. Must be U.S. Citizen or permanent resident by award time. Diverse backgrounds including underrepresented groups encouraged. Confirm the full requirements in the official notice before applying.
The most recent published deadline was June 12, 2025, which has passed. This is an annual program, so a new cycle should follow. Check the funder's website for the next application window.
NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32 - Independent Clinical Trial Not Allowed) is funded by National Cancer Institute (NCI). Verify program details on the funder's official page before applying.
Yes — this listing is flagged as national in scope, so applicants across the U.S. may apply, subject to the sponsor's other eligibility criteria.
Applications go through the funder's official portal — the Apply Now link on this page goes there directly.
Pancreatic Cancer Detection Consortium: Research Units (U01 Clinical Trial Optional) is sponsored by National Cancer Institute (NCI). This Notice of Funding Opportunity (NOFO) from the NCI solicits applications for Research Units (RUs) to conduct research on the early detection of pancreatic ductal adenocarcinoma (PDAC) and the characterization of its precursor lesions.
The Experimental Therapeutics Clinical Trials Network (ETCTN) Lead Academic Organizations (UM1 Clinical Trial Required) is sponsored by National Cancer Institute (NCI). This opportunity from the National Cancer Institute (NCI) is for the Experimental Therapeutics Clinical Trials Network (ETCTN) Lead Academic Organizations. This is a cooperative agreement (UM1) and requires a clinical trial.